Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 196

1.

Incremental Prognostic Value of Platelet Count in Patients With Acute Heart Failure - A Retrospective Observational Study.

Yamaguchi S, Abe M, Arakaki T, Arasaki O, Shimabukuro M.

Circ J. 2018 Dec 29. doi: 10.1253/circj.CJ-18-0961. [Epub ahead of print]

2.

Activation of Toll-Like Receptor 9 Impairs Blood Flow Recovery After Hind-Limb Ischemia.

Nishimoto S, Aini K, Fukuda D, Higashikuni Y, Tanaka K, Hirata Y, Yagi S, Kusunose K, Yamada H, Soeki T, Shimabukuro M, Sata M.

Front Cardiovasc Med. 2018 Oct 16;5:144. doi: 10.3389/fcvm.2018.00144. eCollection 2018.

3.

Effects of lifestyle on hepatobiliary enzyme abnormalities following the Fukushima Daiichi nuclear power plant accident: The Fukushima health management survey.

Takahashi A, Ohira T, Okazaki K, Yasumura S, Sakai A, Maeda M, Yabe H, Hosoya M, Ohtsuru A, Kawasaki Y, Suzuki H, Shimabukuro M, Sugiura Y, Shishido H, Hayashi Y, Nakano H, Kobashi G, Kamiya K, Ohira H.

Medicine (Baltimore). 2018 Oct;97(42):e12890. doi: 10.1097/MD.0000000000012890.

4.

Inhibition of Atherosclerotic Plaque Development by Oral Administration of α-Glucosyl Hesperidin and Water-Dispersible Hesperetin in Apolipoprotein E Knockout Mice.

Sugasawa N, Katagi A, Kurobe H, Nakayama T, Nishio C, Takumi H, Higashiguchi F, Aihara KI, Shimabukuro M, Sata M, Kitagawa T.

J Am Coll Nutr. 2019 Jan;38(1):15-22. doi: 10.1080/07315724.2018.1468831. Epub 2018 Oct 15.

PMID:
30321103
5.

Usefulness of Epicardial Adipose Tissue Volume to Predict Recurrent Atrial Fibrillation After Radiofrequency Catheter Ablation.

Maeda M, Oba K, Yamaguchi S, Arasaki O, Sata M, Masuzaki H, Shimabukuro M.

Am J Cardiol. 2018 Nov 15;122(10):1694-1700. doi: 10.1016/j.amjcard.2018.08.005. Epub 2018 Aug 21.

PMID:
30244845
6.

Low fasting plasma glucose level as a predictor of new-onset diabetes mellitus on a large cohort from a Japanese general population.

Ogata E, Asahi K, Yamaguchi S, Iseki K, Sato H, Moriyama T, Yamagata K, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Shibagaki Y, Kasahara M, Watanabe T, Shimabukuro M.

Sci Rep. 2018 Sep 17;8(1):13927. doi: 10.1038/s41598-018-31744-4.

7.

The prognostic impact of a concentric left ventricular structure evaluated by transthoracic echocardiography in patients with acute decompensated heart failure: A retrospective study.

Yamaguchi S, Abe M, Arasaki O, Shimabukuro M, Ueda S.

Int J Cardiol. 2018 Jul 27. pii: S0167-5273(18)33131-0. doi: 10.1016/j.ijcard.2018.07.097. [Epub ahead of print]

PMID:
30158067
8.

Association of Decreased Docosahexaenoic Acid Level After Statin Therapy and Low Eicosapentaenoic Acid Level with In-Stent Restenosis in Patients with Acute Coronary Syndrome.

Yagi S, Kondo D, Ise T, Fukuda D, Yamaguchi K, Wakatsuki T, Kawabata Y, Ito H, Saijo Y, Seno H, Sutou K, Ueno R, Todoroki T, Kusunose K, Matsuura T, Tobiume T, Yamada H, Soeki T, Shimabukuro M, Aihara KI, Akaike M, Sata M.

J Atheroscler Thromb. 2018 Aug 21. doi: 10.5551/jat.44735. [Epub ahead of print]

9.

Brown rice-specific γ-oryzanol as a promising prophylactic avenue to protect against diabetes mellitus and obesity in humans.

Masuzaki H, Kozuka C, Okamoto S, Yonamine M, Tanaka H, Shimabukuro M.

J Diabetes Investig. 2019 Jan;10(1):18-25. doi: 10.1111/jdi.12892. Epub 2018 Aug 21. Review.

10.

Preliminary Evidence for Adipocytokine Signals in Skeletal Muscle Glucose Uptake.

Kudoh A, Satoh H, Hirai H, Watanabe T, Shimabukuro M.

Front Endocrinol (Lausanne). 2018 Jun 7;9:295. doi: 10.3389/fendo.2018.00295. eCollection 2018.

11.

Activity of xanthine oxidase in plasma correlates with indices of insulin resistance and liver dysfunction in patients with type 2 diabetes mellitus and metabolic syndrome: A pilot exploratory study.

Sunagawa S, Shirakura T, Hokama N, Kozuka C, Yonamine M, Namba T, Morishima S, Nakachi S, Nishi Y, Ikema T, Okamoto S, Matsui C, Hase N, Tamura M, Shimabukuro M, Masuzaki H.

J Diabetes Investig. 2019 Jan;10(1):94-103. doi: 10.1111/jdi.12870. Epub 2018 Jul 7.

12.

Clinical, Electrocardiographic, and Echocardiographic Parameter Combination Predicts the Onset of Atrial Fibrillation.

Soeki T, Matsuura T, Tobiume T, Bando S, Matsumoto K, Nagano H, Uematsu E, Kusunose K, Ise T, Yamaguchi K, Yagi S, Fukuda D, Yamada H, Wakatsuki T, Shimabukuro M, Sata M.

Circ J. 2018 Aug 24;82(9):2253-2258. doi: 10.1253/circj.CJ-17-0758. Epub 2018 May 30.

13.

Effect of the Epicardial Adipose Tissue Volume on the Prevalence of Paroxysmal and Persistent Atrial Fibrillation.

Oba K, Maeda M, Maimaituxun G, Yamaguchi S, Arasaki O, Fukuda D, Yagi S, Hirata Y, Nishio S, Iwase T, Takao S, Kusunose K, Yamada H, Soeki T, Wakatsuki T, Harada M, Masuzaki H, Sata M, Shimabukuro M.

Circ J. 2018 Jun 25;82(7):1778-1787. doi: 10.1253/circj.CJ-18-0021. Epub 2018 May 25.

14.

Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.

Hara T, Phuong PT, Fukuda D, Yamaguchi K, Murata C, Nishimoto S, Yagi S, Kusunose K, Yamada H, Soeki T, Wakatsuki T, Imoto I, Shimabukuro M, Sata M.

Circulation. 2018 Oct 16;138(16):1706-1719. doi: 10.1161/CIRCULATIONAHA.118.033544.

PMID:
29700120
15.

Minimal Shortening of Leukocyte Telomere Length Across Age Groups in a Cross-Sectional Study for Carriers of a Longevity-Associated FOXO3 Allele.

Davy PMC, Willcox DC, Shimabukuro M, Donlon TA, Torigoe T, Suzuki M, Higa M, Masuzaki H, Sata M, Chen R, Murkofsky RL, Morris BJ, Lim E, Allsopp RC, Willcox BJ.

J Gerontol A Biol Sci Med Sci. 2018 Oct 8;73(11):1448-1452. doi: 10.1093/gerona/gly071.

PMID:
29688278
16.

Local Thickness of Epicardial Adipose Tissue Surrounding the Left Anterior Descending Artery Is a Simple Predictor of Coronary Artery Disease - New Prediction Model in Combination With Framingham Risk Score.

Maimaituxun G, Shimabukuro M, Fukuda D, Yagi S, Hirata Y, Iwase T, Takao S, Matsuura T, Ise T, Kusunose K, Tobiume T, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Harada M, Sata M.

Circ J. 2018 Apr 25;82(5):1369-1378. doi: 10.1253/circj.CJ-17-1289. Epub 2018 Mar 21.

17.

Effect of Anagliptin and Sitagliptin on Low-Density Lipoprotein Cholesterol in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: Rationale and Study Design of the REASON Trial.

Ueda S, Shimabukuro M, Arasaki O, Node K, Nomiyama T, Morimoto T.

Cardiovasc Drugs Ther. 2018 Feb;32(1):73-80. doi: 10.1007/s10557-018-6776-z.

18.

[Bowel Perforation in a Patient with Adult T-Cell Leukemia/Lymphoma].

Ota S, Sunagawa T, Shimabukuro M, Mitsumoto Y, Tanimoto A.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1494-1496. Review. Japanese.

PMID:
29394679
19.

Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury.

Hara T, Fukuda D, Tanaka K, Higashikuni Y, Hirata Y, Yagi S, Soeki T, Shimabukuro M, Sata M.

Eur J Pharmacol. 2018 Feb 5;820:222-228. doi: 10.1016/j.ejphar.2017.12.037. Epub 2017 Dec 18.

PMID:
29269019
20.

Predictors for the Treatment Effect of Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes Mellitus.

Yagi S, Aihara KI, Kondo T, Kurahashi K, Yoshida S, Endo I, Fukuda D, Nakaya Y, Suwaki KI, Takeji T, Wada T, Salim HM, Hama S, Matsuura T, Ise T, Kusunose K, Yamaguchi K, Tobiume T, Yamada H, Soeki T, Wakatsuki T, Matsuhisa M, Shimabukuro M, Akaike M, Sata M.

Adv Ther. 2018 Jan;35(1):124-134. doi: 10.1007/s12325-017-0639-z. Epub 2017 Nov 28.

PMID:
29185199
21.

Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus.

Yagi S, Hirata Y, Ise T, Kusunose K, Yamada H, Fukuda D, Salim HM, Maimaituxun G, Nishio S, Takagawa Y, Hama S, Matsuura T, Yamaguchi K, Tobiume T, Soeki T, Wakatsuki T, Aihara KI, Akaike M, Shimabukuro M, Sata M.

Diabetol Metab Syndr. 2017 Oct 4;9:78. doi: 10.1186/s13098-017-0275-4. eCollection 2017.

22.

Improved Exercise Capacity After Cardiac Rehabilitation Is Associated with Reduced Visceral Fat in Patients with Chronic Heart Failure.

Takagawa Y, Yagi S, Ise T, Ishii A, Nishikawa K, Fukuda D, Kusunose K, Matsuura T, Tobiume T, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Katoh S, Aihara KI, Akaike M, Sata M.

Int Heart J. 2017 Oct 21;58(5):746-751. doi: 10.1536/ihj.16-454. Epub 2017 Sep 30.

23.

Low Serum Levels of Eicosapentaenoic Acid and Docosahexaenoic Acid are Risk Factors for Cardiogenic Syncope in Patients with Brugada Syndrome.

Yagi S, Soeki T, Aihara KI, Fukuda D, Ise T, Kadota M, Bando S, Matsuura T, Tobiume T, Yamaguchi K, Kusunose K, Yamada H, Wakatsuki T, Shimabukuro M, Akaike M, Sata M.

Int Heart J. 2017 Oct 21;58(5):720-723. doi: 10.1536/ihj.16-278. Epub 2017 Sep 30.

24.

Echocardiographic Epicardial Adipose Tissue Thickness Is Associated with Symptomatic Coronary Vasospasm during Provocative Testing.

Nishio S, Kusunose K, Yamada H, Hirata Y, Ise T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Shimabukuro M, Sata M.

J Am Soc Echocardiogr. 2017 Oct;30(10):1021-1027.e1. doi: 10.1016/j.echo.2017.06.024. Epub 2017 Aug 23.

PMID:
28843368
25.

n-3 Polyunsaturated Fatty Acids: Promising Nutrients for Preventing Cardiovascular Disease.

Yagi S, Fukuda D, Aihara KI, Akaike M, Shimabukuro M, Sata M.

J Atheroscler Thromb. 2017 Oct 1;24(10):999-1010. doi: 10.5551/jat.RV17013. Epub 2017 Aug 24. Review.

26.

Leptin Resistance and Lipolysis of White Adipose Tissue: An Implication to Ectopic Fat Disposition and Its Consequences.

Shimabukuro M.

J Atheroscler Thromb. 2017 Nov 1;24(11):1088-1089. doi: 10.5551/jat.ED083. Epub 2017 Aug 5. No abstract available.

27.

Perceptual Biases in Font Size as a Data Encoding.

Alexander EC, Chang CC, Shimabukuro M, Franconeri S, Collins C, Gleicher M.

IEEE Trans Vis Comput Graph. 2018 Aug;24(8):2397-2410. doi: 10.1109/TVCG.2017.2723397. Epub 2017 Jul 4.

PMID:
28692979
28.

α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study.

Shimabukuro M, Tanaka A, Sata M, Dai K, Shibata Y, Inoue Y, Ikenaga H, Kishimoto S, Ogasawara K, Takashima A, Niki T, Arasaki O, Oshiro K, Mori Y, Ishihara M, Node K; Collaborators on the Effect of Miglitol on Glucose Metabolism in Acute Coronary Syndrome (MACS) Study.

Cardiovasc Diabetol. 2017 Jul 6;16(1):86. doi: 10.1186/s12933-017-0571-1.

29.

Gender-linked impact of epicardial adipose tissue volume in patients who underwent coronary artery bypass graft surgery or non-coronary valve surgery.

Maimaituxun G, Shimabukuro M, Salim HM, Tabata M, Yuji D, Morimoto Y, Akasaka T, Matsuura T, Yagi S, Fukuda D, Yamada H, Soeki T, Sugimoto T, Tanaka M, Takanashi S, Sata M.

PLoS One. 2017 Jun 8;12(6):e0177170. doi: 10.1371/journal.pone.0177170. eCollection 2017.

30.

Plasma brain natriuretic peptide levels are elevated in patients with cancer.

Bando S, Soeki T, Matsuura T, Tobiume T, Ise T, Kusunose K, Yamaguchi K, Yagi S, Fukuda D, Iwase T, Yamada H, Wakatsuki T, Shimabukuro M, Muguruma N, Takayama T, Kishimoto I, Kangawa K, Sata M.

PLoS One. 2017 Jun 1;12(6):e0178607. doi: 10.1371/journal.pone.0178607. eCollection 2017.

31.

Adiponectin and T-Cadherin: a Tree for Biomarkers in ST-Elevation or Non-ST-Elevation Myocardial Infarction.

Shimabukuro M.

J Atheroscler Thromb. 2017 Aug 1;24(8):788-790. doi: 10.5551/jat.ED073. Epub 2017 May 15. No abstract available.

32.

Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial.

Tanaka A, Shimabukuro M, Okada Y, Taguchi I, Yamaoka-Tojo M, Tomiyama H, Teragawa H, Sugiyama S, Yoshida H, Sato Y, Kawaguchi A, Ikehara Y, Machii N, Maruhashi T, Shima KR, Takamura T, Matsuzawa Y, Kimura K, Sakuma M, Oyama JI, Inoue T, Higashi Y, Ueda S, Node K; EMBLEM Trial Investigators.

Cardiovasc Diabetol. 2017 Apr 12;16(1):48. doi: 10.1186/s12933-017-0532-8.

33.

Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice.

Salim HM, Fukuda D, Higashikuni Y, Tanaka K, Hirata Y, Yagi S, Soeki T, Shimabukuro M, Sata M.

Vascul Pharmacol. 2017 Sep;96-98:19-25. doi: 10.1016/j.vph.2017.03.003. Epub 2017 Mar 27.

PMID:
28347868
34.

[Programs for Continuing Medical Education 2016: A Session: 4. Obesity Disease and Metabolic Syndrome: Clinical Progress and Future Outlook].

Masuzaki H, Shimabukuro M.

Nihon Naika Gakkai Zasshi. 2017 Mar;106(3):477-83. Japanese. No abstract available.

PMID:
30182687
35.

Glycemic Control with Ipragliflozin, a Novel Selective SGLT2 Inhibitor, Ameliorated Endothelial Dysfunction in Streptozotocin-Induced Diabetic Mouse.

Salim HM, Fukuda D, Yagi S, Soeki T, Shimabukuro M, Sata M.

Front Cardiovasc Med. 2016 Oct 26;3:43. eCollection 2016.

36.

Combination of n-3 polyunsaturated fatty acids reduces atherogenesis in apolipoprotein E-deficient mice by inhibiting macrophage activation.

Takashima A, Fukuda D, Tanaka K, Higashikuni Y, Hirata Y, Nishimoto S, Yagi S, Yamada H, Soeki T, Wakatsuki T, Taketani Y, Shimabukuro M, Sata M.

Atherosclerosis. 2016 Nov;254:142-150. doi: 10.1016/j.atherosclerosis.2016.10.002. Epub 2016 Oct 5.

PMID:
27744130
37.

Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study.

Tanaka A, Murohara T, Taguchi I, Eguchi K, Suzuki M, Kitakaze M, Sato Y, Ishizu T, Higashi Y, Yamada H, Nanasato M, Shimabukuro M, Teragawa H, Ueda S, Kodera S, Matsuhisa M, Kadokami T, Kario K, Nishio Y, Inoue T, Maemura K, Oyama J, Ohishi M, Sata M, Tomiyama H, Node K; PROTECT Study Investigators.

Cardiovasc Diabetol. 2016 Sep 13;15(1):133. doi: 10.1186/s12933-016-0449-7.

38.

The pathophysiological role of oxidized cholesterols in epicardial fat accumulation and cardiac dysfunction: a study in swine fed a high caloric diet with an inhibitor of intestinal cholesterol absorption, ezetimibe.

Shimabukuro M, Okawa C, Yamada H, Yanagi S, Uematsu E, Sugasawa N, Kurobe H, Hirata Y, Kim-Kaneyama JR, Lei XF, Takao S, Tanaka Y, Fukuda D, Yagi S, Soeki T, Kitagawa T, Masuzaki H, Sato M, Sata M.

J Nutr Biochem. 2016 Sep;35:66-73. doi: 10.1016/j.jnutbio.2016.05.010. Epub 2016 May 31.

PMID:
27416363
39.

Impact of individual metabolic risk components or its clustering on endothelial and smooth muscle cell function in men.

Shimabukuro M, Higa N, Masuzaki H, Sata M, Ueda S.

Cardiovasc Diabetol. 2016 May 17;15:77. doi: 10.1186/s12933-016-0394-5.

40.

Depot- and gender-specific expression of NLRP3 inflammasome and toll-like receptors in adipose tissue of cancer patients.

Shimabukuro M, Sato H, Izaki H, Fukuda D, Uematsu E, Hirata Y, Yagi S, Soeki T, Sakaue H, Kanayama HO, Masuzaki H, Sata M.

Biofactors. 2016 Jul 8;42(4):397-406. doi: 10.1002/biof.1287. Epub 2016 Apr 18.

PMID:
27086574
41.

Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance.

Nishimoto S, Fukuda D, Higashikuni Y, Tanaka K, Hirata Y, Murata C, Kim-Kaneyama JR, Sato F, Bando M, Yagi S, Soeki T, Hayashi T, Imoto I, Sakaue H, Shimabukuro M, Sata M.

Sci Adv. 2016 Mar 25;2(3):e1501332. doi: 10.1126/sciadv.1501332. eCollection 2016 Mar.

42.

Lipid-laden cells differentially distributed in the aging brain are functionally active and correspond to distinct phenotypes.

Shimabukuro MK, Langhi LG, Cordeiro I, Brito JM, Batista CM, Mattson MP, Mello Coelho Vd.

Sci Rep. 2016 Mar 31;6:23795. doi: 10.1038/srep23795.

43.

Respiratory Collapse of the Inferior Vena Cava Reflects Volume Shift and Subsequent Fluid Refill in Acute Heart Failure Syndrome.

Asahi T, Nakata M, Higa N, Manita M, Tabata K, Shimabukuro M.

Circ J. 2016 Apr 25;80(5):1171-7. doi: 10.1253/circj.CJ-15-1374. Epub 2016 Mar 29.

44.

A New Plausible Link between Lysophosphatidylcholine, TGF-β, and Fibromuscular Dysplasia.

Shimabukuro M.

J Atheroscler Thromb. 2016 Jun 1;23(6):665-7. doi: 10.5551/jat.ED040. Epub 2016 Mar 23. No abstract available.

45.

Relationship between local production of microRNA-328 and atrial substrate remodeling in atrial fibrillation.

Soeki T, Matsuura T, Bando S, Tobiume T, Uematsu E, Ise T, Kusunose K, Yamaguchi K, Yagi S, Fukuda D, Yamada H, Wakatsuki T, Shimabukuro M, Sata M.

J Cardiol. 2016 Dec;68(6):472-477. doi: 10.1016/j.jjcc.2015.12.007. Epub 2016 Mar 15.

46.

Deep-sea whale fall fauna from the Atlantic resembles that of the Pacific Ocean.

Sumida PY, Alfaro-Lucas JM, Shimabukuro M, Kitazato H, Perez JA, Soares-Gomes A, Toyofuku T, Lima AO, Ara K, Fujiwara Y.

Sci Rep. 2016 Feb 24;6:22139. doi: 10.1038/srep22139.

47.

Screening of Coronary Artery Disease in Diabetic Patients: Who and How? - Reply.

Shimabukuro M, Saito T, Masuzaki H, Sata M.

Circ J. 2016;80(2):544. doi: 10.1253/circj.CJ-15-1377. Epub 2016 Jan 15. No abstract available.

48.

Erratum to: 'Reduced ratio of eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid is associated with early onset of acute coronary syndrome'.

Yagi S, Aihara K, Fukuda D, Takashima A, Bando M, Hara T, Nishimoto S, Ise T, Kusunose K, Yamaguchi K, Tobiume T, Iwase T, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Akaike M, Sata M.

Nutr J. 2015 Dec 1;14:121. doi: 10.1186/s12937-015-0112-2. No abstract available.

49.

Carbon mineralization pathways and bioturbation in coastal Brazilian sediments.

Quintana CO, Shimabukuro M, Pereira CO, Alves BG, Moraes PC, Valdemarsen T, Kristensen E, Sumida PY.

Sci Rep. 2015 Nov 3;5:16122. doi: 10.1038/srep16122.

50.

Reduced ratio of eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid is associated with early onset of acute coronary syndrome.

Yagi S, Aihara K, Fukuda D, Takashima A, Bando M, Hara T, Nishimoto S, Ise T, Kusunose K, Yamaguchi K, Tobiume T, Iwase T, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Akaike M, Sata M.

Nutr J. 2015 Oct 29;14:111. doi: 10.1186/s12937-015-0102-4. Erratum in: Nutr J. 2015;14:121.

Supplemental Content

Loading ...
Support Center